Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy clinical trials

Explore recruiting patients with hepatocellular carcinoma hcc and child pugh b albi grade 1 or 2 liver function pretreated or not by tyrosine kinase inhibitors and not pretreated with immunotherapy clinical trials.

Also recruiting in Europe

Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HESTIA : A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function Score.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy trials by city

Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Toronto Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Vancouver Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Montreal Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Calgary Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Edmonton Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Ottawa Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Winnipeg Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Quebec City Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Hamilton Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Kitchener Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in London Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Halifax Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in New York Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Los Angeles Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Chicago Patients With Hepatocellular Carcinoma Hcc And Child Pugh B Albi Grade 1 Or 2 Liver Function Pretreated Or Not By Tyrosine Kinase Inhibitors And Not Pretreated With Immunotherapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease